BlueLight Therapeutics

BlueLight Therapeutics is a biotech company in South San Francisco, United States. It has raised $45.0M across 3 rounds, most recently a $20.0M Series C in September 2018.

Structure-driven drug discovery

Employees
11–50
Business Model
B2B
Total Funding
$45.0M
Last Round
$20.0M Series CSep 2018
Rounds
3

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 3 funding rounds and 3 investors for this company. The full record is or through the API.

About

BlueLight Therapeutics is a South San Francisco-based biotechnology company that leverages a proprietary, structure-driven platform to develop novel therapeutic molecules against challenging, high-value drug targets. The company uses Second Harmonic Generation (SHG) technology to measure structural changes of biomolecules in real time and at high throughput, enabling discovery of structure-modulating compounds missed by standard activity assays. By coupling knowledge of a drug target's native and disease-relevant biology with this platform, BlueLight can efficiently discover and develop molecules that induce functionally relevant conformational changes in difficult-to-drug targets. The company partners with biopharma organizations to drive discovery and development of novel therapeutics. BlueLight Therapeutics was formerly known as Biodesy Inc., adopting its current name in May 2020. Its investors include 5AM Ventures, Pfizer Ventures, and Alexandria Venture Investments.

Summary

It lists 11–50 employees. It has raised $45.0M in total across 3 rounds, most recently a $20.0M Series C round in Sep 2018. Investors include 5AM Ventures, Pfizer Ventures and Roche.

Tech & App Stack

4 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Data from Indexed.vcUpdated
Series CSeries CSep 2018
$20.0M

Sign up to see all 3 events

Funding: Series A through Series C. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

BlueLight Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/bluelight-therapeutics"><img src="https://indexed.vc/api/badge/company/bluelight-therapeutics" alt="BlueLight Therapeutics on Indexed.vc" width="260" height="76" /></a>